These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33031714)

  • 1. Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
    Wheless JW
    Expert Rev Neurother; 2020 Nov; 20(11):1085-1098. PubMed ID: 33031714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cenobamate tablets as a treatment for focal-onset seizures in adults.
    Steinhoff BJ
    Expert Rev Clin Pharmacol; 2021 Feb; 14(2):161-172. PubMed ID: 33470139
    [No Abstract]   [Full Text] [Related]  

  • 3. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
    Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
    Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
    Sperling MR; Klein P; Aboumatar S; Gelfand M; Halford JJ; Krauss GL; Rosenfeld WE; Vossler DG; Wechsler R; Borchert L; Kamin M
    Epilepsia; 2020 Jun; 61(6):1099-1108. PubMed ID: 32396252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.
    Lattanzi S; Trinka E; Zaccara G; Striano P; Del Giovane C; Silvestrini M; Brigo F
    CNS Drugs; 2020 Nov; 34(11):1105-1120. PubMed ID: 32851590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cenobamate add-on therapy for drug-resistant focal epilepsy.
    Brigo F; Lattanzi S
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014941. PubMed ID: 39087564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study.
    Winter Y; Abou Dargham R; Patiño Tobón S; Groppa S; Fuest S
    CNS Drugs; 2024 Sep; 38(9):733-742. PubMed ID: 39096467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
    Rosenfeld WE; Nisman A; Ferrari L
    Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
    Zhang L; Wang J; Wang C
    Acta Neurol Scand; 2021 Jul; 144(1):58-66. PubMed ID: 33788253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain.
    Rodríguez-Uranga JJ; Sánchez-Caro JM; Hariramani Ramchandani R
    Epilepsia Open; 2024 Aug; 9(4):1345-1356. PubMed ID: 38800945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study.
    Serrano-Castro PJ; Ramírez-García T; Cabezudo-Garcia P; Garcia-Martin G; De La Parra J
    CNS Drugs; 2024 Feb; 38(2):141-151. PubMed ID: 38265735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study.
    O'Dwyer R; Stern S; Wade CT; Guggilam A; Rosenfeld WE
    Drugs Aging; 2024 Mar; 41(3):251-260. PubMed ID: 38446341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cenobamate: A New Adjunctive Agent for Drug-Resistant Focal Onset Epilepsy.
    Buckley CT; Waters OR; DeMaagd G
    Ann Pharmacother; 2021 Mar; 55(3):318-329. PubMed ID: 32623899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability.
    Roberti R; De Caro C; Iannone LF; Zaccara G; Lattanzi S; Russo E
    CNS Drugs; 2021 Jun; 35(6):609-618. PubMed ID: 33993416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
    Rosenfeld WE; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Krauss GL; Sperling MR; Vossler DG; Klein P; Wechsler R
    Epilepsia; 2021 Dec; 62(12):3016-3028. PubMed ID: 34633074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
    Krauss GL; Klein P; Brandt C; Lee SK; Milanov I; Milovanovic M; Steinhoff BJ; Kamin M
    Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
    Varughese RT; Shah YD; Karkare S; Kothare SV
    Epilepsy Behav; 2022 May; 130():108679. PubMed ID: 35381496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cenobamate for the treatment of focal epilepsies.
    Strzelczyk A; Mann C; Willems LM; Rosenow F; Bauer S
    Expert Opin Pharmacother; 2020 Dec; 21(18):2215-2223. PubMed ID: 32812825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of cenobamate with other newer antiseizure medications for adjunctive treatment of focal-onset seizures: A systematic review and network meta-analysis.
    Mulheron S; Leahy TP; McStravick M; Doran R; Delanty N
    Seizure; 2024 May; 118():80-90. PubMed ID: 38643679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of efficacy and adverse events during Cenobamate titration period.
    Steinhoff BJ; Ben-Menachem E; Brandt C; García Morales I; Rosenfeld WE; Santamarina E; Serratosa JM
    Acta Neurol Scand; 2022 Sep; 146(3):265-275. PubMed ID: 35711112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.